Although there are no approved medications for ADHD that target nicotinic acetylcholine receptor (nAChR) function, results from many clinical trials have been reviewed, revealing that nicotinic drugs are typically well tolerated and present only mild-to-moderate side effects [97]. This evidence concerns the gene CHRNA4 and attention deficit-hyperactivity disorder.